Globe Life Inc. (GL) Stock Analysis
Financial Services · Insurance - Life
Sell if holding. Analyst target reached at $153.20 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (1.2% away).
Globe Life Inc. is an insurance holding company selling individual life and supplemental health insurance through five U.S. distribution channels—Globe Life And Accident, American Income Life, Liberty National, Family Heritage, and United American—with $3.4B in annualized life... Read more
Sell if holding. Analyst target reached at $153.20 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (1.2% away). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.7/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, no SEC red flags, news boost analyst 0.60, earnings proximity 83d clear, semi cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMProductMedicare Supplement10-K Item 1A: 'A significant percentage of the supplemental health insurance premiums that our insurance subsidiaries earn is from Medicare Supplement insurance'
- MEDIUMCustomerFHLB funding concentration10-K Item 1A: 'We are subject to liquidity risks associated with sourcing a concentration of our funding from the FHLB'
Material Events(8-K, last 90d)
- 2026-02-27Item 5.02LOWGlobe Life Board expanded from 12 to 14 directors on February 25, 2026; Derek T. Kan and Sandra L. Phillips appointed to fill new seats. Kan named to Audit Committee; Phillips named to Governance and Nominating Committee. No departures cited.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
10 dimensions · all in-band
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $153.20 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (1.2% away). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $146.98. Score 5.7/10, moderate confidence.
Take-profit target: $151.98 (-0.8% upside). Prior stop was $146.98. Stop-loss: $146.98.
Analyst target reached - limited upside remaining; Near 52-week high (1.2% away); Consecutive earnings misses (2).
Globe Life Inc. trades at a P/E of 10.6 (forward 9.2). TrendMatrix value score: 7.7/10. Verdict: Sell.
22 analysts cover GL with a consensus score of 4.0/5. Average price target: $173.
What does Globe Life Inc. do?Globe Life Inc. is an insurance holding company selling individual life and supplemental health insurance through five...
Globe Life Inc. is an insurance holding company selling individual life and supplemental health insurance through five U.S. distribution channels—Globe Life And Accident, American Income Life, Liberty National, Family Heritage, and United American—with $3.4B in annualized life premium in force. Revenue derives primarily from recurring premiums on policies sold to lower-middle-income households via direct-to-consumer and exclusive agents.